Skip to main content

Day: October 18, 2022

BTCS Inc. Announces Strategic Investment in the Operator of Upstream, a Securities Exchange Built on Ethereum’s Blockchain

Silver Spring, MD, Oct. 18, 2022 (GLOBE NEWSWIRE) — BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a blockchain technology-focused company, announced today a $100,000 strategic investment in GlobexUS Holdings Corp; the parent of Horizon Globex GmbH, the technology provider and joint venture partner of the Upstream exchange. Upstream, a MERJ Exchange market, is an affiliate of the World Federation of Exchanges and the first securities exchange and trading app built on Ethereum’s blockchain and operated under a securities exchange license and regulations. BTCS’ investment in the technology provider powering Upstream’s on-chain orderbook and innovative trading app represents the Company’s strong belief in the power and enhanced use cases of blockchain technologies. We believe Upstream’s market unlocks the potential for companies...

Continue reading

Nuvectis Phrama Announces Two Upcoming Poster Presentations at the 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

FORT LEE, N.J., Oct. 18, 2022 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis” or the “Company”), a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced the publication of abstracts for two posters that will be presented at the upcoming 34th EORTC-NCI-AACR Symposium on molecular targets and cancer therapeutics (“2022 ENA”), taking place from October 26th to October 28th, 2022 in Barcelona, Spain. Ron Bentsur, Chairman and Chief Executive Officer of Nuvectis said: “The posters that will be presented at the 2022 ENA describe the preclinical validation of biomarkers supporting the clinical development of NXP800, and identify additional target tumors and potential clinical development opportunities...

Continue reading

OrthoPediatrics Corp. to Report Third Quarter 2022 Financial Results on November 1, 2022

WARSAW, Ind., Oct. 18, 2022 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its third quarter 2022 financial results on Monday, October 31, 2022, after the market closes. OrthoPediatrics will host a conference call on Tuesday, November 1, 2022, at 8:00 a.m. ET to discuss the results. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be available for replay for at least 90 days after the event. About OrthoPediatrics Corp.Founded in 2006, OrthoPediatrics is an orthopedic company...

Continue reading

Comera Life Sciences Announces Favorable Preclinical Results of Lead SQore Excipient in SEQURUS-2 Study

WOBURN, Mass., Oct. 18, 2022 (GLOBE NEWSWIRE) — Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety and convenience, today announced favorable results from its recently completed SEQURUS-2 study. Together with the SEQURUS-1 study, the preclinical results showed that Comera’s caffeine-based SQore™ excipient did not result in local or systemic toxicity and had no impact on any measured pharmacokinetic (PK) parameters of ipilimumab when administered subcutaneously. Comera is using its proprietary formulation platform SQore to enable subcutaneous (SQ) delivery of intravenous (IV) drugs such as monoclonal antibodies (mAbs). The addition of excipients, such as caffeine, interrupts intermolecular interactions...

Continue reading

LogicMark to Present at the LD Micro Main Event XV

LOUISVILLE, Ky., Oct. 18, 2022 (GLOBE NEWSWIRE) — LogicMark, Inc. (Nasdaq: LGMK) (the “Company” or “LogicMark”), a provider of personal emergency response systems (PERS), health communications devices, and technology for the growing care economy, today announced that Chia-Lin Simmons, Chief Executive Officer and Mark Archer, Chief Financial Officer will present a corporate overview at the LD Micro Main Event XV. The conference is being held on October 25 – 27, 2022 at the Luxe Sunset Boulevard Hotel in Los Angeles.Event:     LD Micro Main Event XVPresentation Date:     Tuesday, October 25Time:     1:00pm PT (Track 5)Register to watch the presentation here. Ms. Simmons and Mr. Archer will be available for one-on-one meetings throughout the conference. About LogicMark, Inc. LogicMark, Inc. (Nasdaq: LGMK) provides personal...

Continue reading

Red Cat Holdings to Present at the LD Micro Main Event XV

SAN JUAN, Puerto Rico, Oct. 18, 2022 (GLOBE NEWSWIRE) — Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat” or the “Company”), a hardware-enabled software provider to the drone industry, announces today that Chief Operating Officer Dr. Allan Evans will present a corporate overview at the LD Micro Main Event XV. The conference is being held on October 25 – 27, 2022 at the Luxe Sunset Boulevard Hotel in Los Angeles.Event: LD Micro Main Event XVPresentation Date: Wednesday, October 26Time:     11:30am PT (Track 2)Register to watch the presentation here. Dr. Evans will be available for one-on-one meetings throughout the conference. About Red Cat Holdings, Inc. Red Cat provides drone-based products, services, and solutions through its four subsidiaries and services the enterprise, military, and consumer...

Continue reading

IPG Photonics to Announce Third Quarter 2022 Financial Results on November 1

OXFORD, Mass., Oct. 18, 2022 (GLOBE NEWSWIRE) — IPG Photonics Corporation (NASDAQ: IPGP) will release its third quarter 2022 financial results before the market opens on Tuesday, November 1, 2022. The company will hold a conference call to review these results at 10:00 a.m. ET on the same day. To access the call, please dial 877-407-6184 in the United States or 201-389-0877 internationally. A live webcast of the call will also be available and archived in the investor relations section of the company’s website at investor.ipgphotonics.com. About IPG Photonics Corporation IPG Photonics Corporation is the leader in high-power fiber lasers and amplifiers used primarily in materials processing and other diverse applications. The company’s mission is to make its fiber laser technology the tool of choice in mass production. IPG accomplishes...

Continue reading

Alignment Health Plan Receives Top Star Rating in North Carolina, High Marks for California Plan Quality

Alignment’s North Carolina HMO plan debuts with highest achievable rating, 1 of 2 Medicare Advantage HMO plans in state to earn coveted 5 stars ORANGE, Calif., Oct. 18, 2022 (GLOBE NEWSWIRE) — Alignment Health, a tech-enabled Medicare Advantage (MA) company, today announced that its HMO plan in North Carolina has landed in the top spot in its first year, earning a coveted 5-star rating out of a possible 5 stars for 2023, while its California HMO plan maintained a notable 4-star rating out of 5 stars, from the Centers for Medicare & Medicaid Services (CMS). The more stars a plan receives, the better the plan. Alignment Health Plan, which entered North Carolina in 2021, is one of two MA HMO plans in the state to achieve a 5-star rating, representing excellent performance. According to CMS data, the plan is one of only 57 MA...

Continue reading

Vistin Pharma ASA: Invitation to Q3 2022 conference call

Oslo, Norway, 18 October 2022 Vistin Pharma ASA will release its third quarter and YTD 2022 results on Wednesday 26th of October 2022. Vistin Pharma will host a conference call for all shareholders and interested parties at the same day; Wednesday 26th of October at 08:30 CET. There will be a Q&A session following the management discussion. The conference call will be held in English. The third quarter conference call will be available via web and audio through the following access points: Webcast: https://edge.media-server.com/mmc/p/ffgh24aq Telephone conference (online registration): https://register.vevent.com/register/BI07bfaf2bbf674f2387a73e982a162114 ***** For further information, please contact: Alexander KarlsenCFO+47 97053621alexander.karlsen@vistin.com About Vistin Pharma | www.vistin.com Vistin Pharma is a Norwegian pharmaceutical...

Continue reading

ShopWithOwners.ca – TELUS Business launches new online platform to support entrepreneurs and connect consumers to local businesses

To celebrate Small Business Month, TELUS Business’ launch of online platform will help Canadians shop local BC-based Gabi & Jules Handmade Pies and Baked Goodness selected as 2022 technology refresh winner for their focus on inclusive hiring and leveraging technology to scale their business VANCOUVER, British Columbia, Oct. 18, 2022 (GLOBE NEWSWIRE) — TELUS Business is celebrating Small Business Month this October with the launch of ShopWithOwners.ca, a new online platform to connect Canadians with their favourite local shops, including past #StandWithOwners winners. This platform will help support business owners across the country with gaining exposure to customers looking for local finds and gifts during the holiday season. Canadians will be able to search by location, keywords and categories to discover exceptional small...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.